122 related articles for article (PubMed ID: 9829977)
21. CD28 mediates a potent costimulatory signal for rapid degradation of IkappaBbeta which is associated with accelerated activation of various NF-kappaB/Rel heterodimers.
Harhaj EW; Maggirwar SB; Good L; Sun SC
Mol Cell Biol; 1996 Dec; 16(12):6736-43. PubMed ID: 8943328
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter.
Parra E; McGuire K; Hedlund G; Dohlsten M
J Immunol; 1998 Jun; 160(11):5374-81. PubMed ID: 9605137
[TBL] [Abstract][Full Text] [Related]
23. Identification of a CD28 response element in the CD40 ligand promoter.
Parra E; Mustelin T; Dohlsten M; Mercola D
J Immunol; 2001 Feb; 166(4):2437-43. PubMed ID: 11160303
[TBL] [Abstract][Full Text] [Related]
24. High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters.
Himes SR; Coles LS; Reeves R; Shannon MF
Immunity; 1996 Nov; 5(5):479-89. PubMed ID: 8934574
[TBL] [Abstract][Full Text] [Related]
25. CD28 co-stimulation restores T cell responsiveness in NOD mice by overcoming deficiencies in Rac-1/p38 mitogen-activated protein kinase signaling and IL-2 and IL-4 gene transcription.
Zhang J; Salojin KV; Delovitch TL
Int Immunol; 2001 Mar; 13(3):377-84. PubMed ID: 11222507
[TBL] [Abstract][Full Text] [Related]
26. Temporal and subunit-specific modulations of the Rel/NF-kappaB transcription factors through CD28 costimulation.
Kahn-Perlès B; Lipcey C; Lécine P; Olive D; Imbert J
J Biol Chem; 1997 Aug; 272(35):21774-83. PubMed ID: 9268307
[TBL] [Abstract][Full Text] [Related]
27. CD28 signaling augments Elk-1-dependent transcription at the c-fos gene during antigen stimulation.
Li W; Whaley CD; Bonnevier JL; Mondino A; Martin ME; Aagaard-Tillery KM; Mueller DL
J Immunol; 2001 Jul; 167(2):827-35. PubMed ID: 11441089
[TBL] [Abstract][Full Text] [Related]
28. CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation.
Raab M; Pfister S; Rudd CE
Immunity; 2001 Dec; 15(6):921-33. PubMed ID: 11754814
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor-1 (FGF-1) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor-bearing Jurkat T cells.
Byrd VM; Ballard DW; Miller GG; Thomas JW
J Immunol; 1999 May; 162(10):5853-9. PubMed ID: 10229820
[TBL] [Abstract][Full Text] [Related]
30. Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element.
Good L; Maggirwar SB; Sun SC
EMBO J; 1996 Jul; 15(14):3744-50. PubMed ID: 8670878
[TBL] [Abstract][Full Text] [Related]
31. The Jun kinase cascade is responsible for activating the CD28 response element of the IL-2 promoter: proof of cross-talk with the I kappa B kinase cascade.
Kempiak SJ; Hiura TS; Nel AE
J Immunol; 1999 Mar; 162(6):3176-87. PubMed ID: 10092768
[TBL] [Abstract][Full Text] [Related]
32. p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells.
Zhang J; Salojin KV; Gao JX; Cameron MJ; Bergerot I; Delovitch TL
J Immunol; 1999 Apr; 162(7):3819-29. PubMed ID: 10201899
[TBL] [Abstract][Full Text] [Related]
33. X-ray crystal structure of proto-oncogene product c-Rel bound to the CD28 response element of IL-2.
Huang DB; Chen YQ; Ruetsche M; Phelps CB; Ghosh G
Structure; 2001 Aug; 9(8):669-78. PubMed ID: 11587641
[TBL] [Abstract][Full Text] [Related]
34. Costimulation reverses the defect in IL-2 but not effector cytokine production by T cells with impaired IkappaBalpha degradation.
Aune TM; Mora AL; Kim S; Boothby M; Lichtman AH
J Immunol; 1999 May; 162(10):5805-12. PubMed ID: 10229814
[TBL] [Abstract][Full Text] [Related]
35. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element.
Verweij CL; Geerts M; Aarden LA
J Biol Chem; 1991 Aug; 266(22):14179-82. PubMed ID: 1650350
[TBL] [Abstract][Full Text] [Related]
36. CD28 is not required for c-Jun N-terminal kinase activation in T cells.
Rivas FV; O'Herrin S; Gajewski TF
J Immunol; 2001 Sep; 167(6):3123-8. PubMed ID: 11544297
[TBL] [Abstract][Full Text] [Related]
37. Nuclear appearance of a factor that binds the CD28 response element within the interleukin-2 enhancer correlates with interleukin-2 production.
Civil A; Bakker A; Rensink I; Doerre S; Aarden LA; Verweij CL
J Biol Chem; 1996 Apr; 271(14):8321-7. PubMed ID: 8626528
[TBL] [Abstract][Full Text] [Related]
38. A role of suppressor of cytokine signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated interleukin 2 production.
Matsumoto A; Seki Y; Watanabe R; Hayashi K; Johnston JA; Harada Y; Abe R; Yoshimura A; Kubo M
J Exp Med; 2003 Feb; 197(4):425-36. PubMed ID: 12591901
[TBL] [Abstract][Full Text] [Related]
39. Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients.
Dieckhoff K; Graf P; Beinhauer B; Schwaerzler C; Carballido JM; Neumann C; Zachmann K; Jung T
Exp Dermatol; 2005 Jan; 14(1):17-25. PubMed ID: 15660915
[TBL] [Abstract][Full Text] [Related]
40. Tyrosine-phosphorylated Vav1 as a point of integration for T-cell receptor- and CD28-mediated activation of JNK, p38, and interleukin-2 transcription.
Hehner SP; Hofmann TG; Dienz O; Droge W; Schmitz ML
J Biol Chem; 2000 Jun; 275(24):18160-71. PubMed ID: 10849438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
